These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2824015)

  • 1. The use of indomethacin, sulindac, and tamoxifen for the treatment of desmoid tumors associated with familial polyposis.
    Klein WA; Miller HH; Anderson M; DeCosse JJ
    Cancer; 1987 Dec; 60(12):2863-8. PubMed ID: 2824015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noncytotoxic drug therapy for intra-abdominal desmoid tumor in patients with familial adenomatous polyposis.
    Tsukada K; Church JM; Jagelman DG; Fazio VW; McGannon E; George CR; Schroeder T; Lavery I; Oakley J
    Dis Colon Rectum; 1992 Jan; 35(1):29-33. PubMed ID: 1310270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcome of sporadic and FAP-associated desmoid tumors treated with high-dose selective estrogen receptor modulators and sulindac: a single-center long-term observational study in 134 patients.
    Quast DR; Schneider R; Burdzik E; Hoppe S; Möslein G
    Fam Cancer; 2016 Jan; 15(1):31-40. PubMed ID: 26275868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testolactone, sulindac, warfarin, and vitamin K1 for unresectable desmoid tumors.
    Waddell WR; Kirsch WM
    Am J Surg; 1991 Apr; 161(4):416-21. PubMed ID: 2035759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenteric desmoid tumor in Gardner's syndrome treated by sulindac.
    Belliveau P; Graham AM
    Dis Colon Rectum; 1984 Jan; 27(1):53-4. PubMed ID: 6690265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic cytotoxic chemotherapy and radiation therapy for desmoid in familial adenomatous polyposis.
    Tsukada K; Church JM; Jagelman DG; Fazio VW; Lavery IC
    Dis Colon Rectum; 1991 Dec; 34(12):1090-2. PubMed ID: 1659977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenteric fibromatosis complicating familial adenomatous polyposis: predisposing factors and results of treatment.
    Lotfi AM; Dozois RR; Gordon H; Hruska LS; Weiland LH; Carryer PW; Hurt RD
    Int J Colorectal Dis; 1989; 4(1):30-6. PubMed ID: 2540254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of eflornithine (CPP-1X)/sulindac combination therapy versus each as monotherapy in patients with familial adenomatous polyposis (FAP): design and rationale of a randomized, double-blind, Phase III trial.
    Burke CA; Dekker E; Samadder NJ; Stoffel E; Cohen A
    BMC Gastroenterol; 2016 Aug; 16(1):87. PubMed ID: 27480131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors.
    Hansmann A; Adolph C; Vogel T; Unger A; Moeslein G
    Cancer; 2004 Feb; 100(3):612-20. PubMed ID: 14745880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulindac for polyposis of the colon.
    Waddell WR; Ganser GF; Cerise EJ; Loughry RW
    Am J Surg; 1989 Jan; 157(1):175-9. PubMed ID: 2535920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desmoid disease in patients with familial adenomatous polyposis.
    Soravia C; Berk T; McLeod RS; Cohen Z
    Dis Colon Rectum; 2000 Mar; 43(3):363-9. PubMed ID: 10733118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulindac plus erlotinib for familial adenomatous polyposis.
    Baker H
    Lancet Oncol; 2016 May; 17(5):e183. PubMed ID: 27051970
    [No Abstract]   [Full Text] [Related]  

  • 13. [Complete remission of a mesenteric fibromatosis after taking sulindac].
    D'Alteroche L; Benchellal ZA; Salem N; Regimbeau C; Picon L; Metman EH
    Gastroenterol Clin Biol; 1998 Dec; 22(12):1098-101. PubMed ID: 10051987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Desmoid tumors or intra-abdominal fibromatoses].
    Lasser P; Elias D; Contesso G; Genin J; Mankarios H; Rougier P
    Ann Chir; 1993; 47(4):352-9. PubMed ID: 8352514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small bowel obstruction in patients with familial adenomatous polyposis related desmoid disease.
    Xhaja X; Church J
    Colorectal Dis; 2013 Dec; 15(12):1489-92. PubMed ID: 24020802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Desmoid tumors in patients with familial adenomatous polyposis (FAP). Clinical and therapeutic observations from the Heidelberg polyposis register].
    Kadmon M; Möslein G; Buhr HJ; Herfarth C
    Chirurg; 1995 Oct; 66(10):997-1005. PubMed ID: 8529453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment with sulindac of adenomatous polyps in familial polyposis].
    Cerdán FJ; Torres-Melero J; Martínez S; Gutiérrez del Olmo A; Balibrea JL
    Rev Esp Enferm Dig; 1995 Aug; 87(8):574-6. PubMed ID: 7577106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulindac for polyposis of the colon.
    Waddell WR; Loughry RW
    J Surg Oncol; 1983 Sep; 24(1):83-7. PubMed ID: 6887943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of nonsteroidal anti-inflammatory drugs (NSAID) on colorectal polyps in patients with familial adenomatous polyposis: a review of clinical studies].
    Akasu T; Kakizoe T
    Nihon Geka Gakkai Zasshi; 1998 Jun; 99(6):385-90. PubMed ID: 9695077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regression of an aggressive abdominal desmoid tumor in a patient with familial adenomatous polyposis by hyperthermoradiotherapy.
    Oohata Y; Mibu R; Uehara S; Iida M; Ishikawa M; Sakai M; Tanaka M
    Am J Gastroenterol; 1997 Jan; 92(1):156-8. PubMed ID: 8995959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.